UnitedHealth's acquisition of Amedisys for $3.3 billion extended to December 31, 2025

From StockTwits: 2024-12-27 10:00:16

UnitedHealth’s Optum unit acquired Amedisys for $100 per share, a 26% premium. The merger deadline extended to Dec. 31, 2025, due to DOJ opposition. Antitrust lawsuit filed against UnitedHealth’s $3.3 billion acquisition. Companies waived right to terminate the deal if not completed by the deadline. A new DOJ regime under President-elect Donald Trump could impact the deal. Amedisys shares rose 4.70%, while UnitedHealth shares dipped 0.23%. Sentiment toward UnitedHealth remains ‘bullish,’ with low message volume. Amedisys sentiment turned ‘neutral’ with extremely high message volume. (Source: Stocktwits)



Read more at StockTwits: UnitedHealth, Amedisys Stocks In Focus As $3.3B Merger Deadline Extended Amid DOJ Wrangling: Retail Guarded